Neurotechnology Market Scope, Share Analysis And Growth 2025

This study helps professionals make sense of complex market trends and competitive shifts affecting the neurotechnology industry today.

What Is The Current Outlook For The Neurotechnology Market By 2025?
The neurotechnology market size has grown rapidly in recent years. It will grow from $15.38 billion in 2024 to $17.34 billion in 2025 at a compound annual growth rate (CAGR) of 12.8%. The growth in the historic period can be attributed to increased research funding, aging population, neurological disorders prevalence, regulatory support, government initiatives.

The neurotechnology market size is expected to see rapid growth in the next few years. It will grow to $29.56 billion in 2029 at a compound annual growth rate (CAGR) of 14.3%. The growth in the forecast period can be attributed to regulatory advancements, genomics and neurological disorders, telemedicine in neurology, precision medicine adoption, development of closed-loop systems. Major trends in the forecast period include neuroinformatics advancements, neuroplasticity interventions, brain mapping initiatives, remote monitoring solutions, non-invasive brain stimulation.

Get your free sample today:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9840&type=smp

What Are The Key Driving Factors For The Growth Of The Neurotechnology Market?
The increased prevalence of neurological conditions is expected to propel the growth of the neurotechnology market going forward. A neurological condition is any disorder or disease that affects the brain, common neurological conditions include Alzheimer's disease, Parkinson's disease, epilepsy, and migraine. Neurotechnology is being used to diagnose and treat neurological disorders in a variety of ways, including brain imaging, neurostimulation, neurofeedback, and brain-computer interfaces. For instance, in January 2022, according to the American Heart Association Inc., a US-based non-profit organization, Alzheimer's disease, and related dementias were expected to affect 9.3 million people in the United States by 2060. Additionally, in February 2023, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization, an estimated 5 million people worldwide will be diagnosed with epilepsy every year. Therefore, the increased prevalence of neurological conditions is driving the growth of the neurotechnology market going forward.

Global Neurotechnology Market Report Segmentation
The neurotechnologymarket covered in this report is segmented –

1) By Conditions: Cognitive Disorders; Pain Treatment; Urinary And Faecal Incontinence; Epilepsy; Parkinson's Disease; Hearing Conditions; Sleep Disorder; Depression; Other Conditions
2) By Type: Imaging Modalities; Neurostimulation; Cranial Surface Measurement; Neurological Implants; Other Types
3) By End Use: Ambulatory Surgical Centers; Hospitals; Homecare Facilities; Other End Uses

Subsegments:
1) By Cognitive Disorders: Alzheimer's Disease; Attention Deficit Hyperactivity Disorder (ADHD); Dementia
2) By Pain Treatment: Chronic Pain; Neuropathic Pain; Acute Pain
3) By Urinary And Fecal Incontinence: Overactive Bladder; Neurogenic Bladder; Fecal Incontinence Management
4) By Epilepsy: Drug-Resistant Epilepsy; Seizure Management Devices
5) By Parkinson's Disease: Motor Symptoms Management; Non-Motor Symptoms Management
6) By Hearing Conditions: Tinnitus; Hearing Loss Solutions
7) By Sleep Disorder: Insomnia; Sleep Apnea; Restless Legs Syndrome
8) By Depression: Major Depressive Disorder; Treatment-Resistant Depression
9) By Other Conditions: Anxiety Disorders; Autism Spectrum Disorder; Traumatic Brain Injury (TBI)

Neurotechnology Market Emerging Trends And Opportunities
Technological advancements are a key trend gaining popularity in the neurotechnology market. Companies operating in the neurotechnology market are adopting new technologies to sustain their position in the market. For instance, in November 2022, Blackrock Neurotech, a US-based biotechnology company, launched Neuralace, a next-generation technology for neurotechnology. Neuralace looks like a piece of lace thinner than an eyelash, and it can cover large areas of the brain's surface. The Neuralace platform was designed as an ultra-high channel count, flexible electrode that provides a glimpse into the technology that will power its future BCIs. The system assisted patients in regaining tactile function, limb and prosthetic movement, and the ability to control digital devices.

Who Are The Leading Players In The Neurotechnology Market?
Major companies operating in the neurotechnology market include General Electric, Medtronic PLC, Koninklijke Philips N.V., Shimadzu Corporation, EndoStim Inc., Elekta AB, Natus Medical Incorporated, Abbott, Boston Scientific Corporation, Cleveland Medical Devices Inc., Nihon Kohden Corporation, LivaNova PLC, Siemens Healthcare Private Limited, Hitachi Medical Corporation, Cochlear Limited, Advanced Bionics AG (Sonova), NeuroPace Inc., NeuroSigma Inc., NeuroMetrix Inc., NeuroSky Inc., NeuroVigil Inc., Neurotech Pharmaceuticals Inc., Neurotech International Limited, NeurotechEU, Neurotech Solutions, Neurotech Reports, Neurotech Research Development

View the full neurotechnology market report here:
https://www.thebusinessresearchcompany.com/report/neurotechnology-global-market-report

Which Region Is Projected To Hold The Largest Market Share In The Global Neurotechnology Market By 2029?
North America was the largest region in the neurotechnology market in 2024. Europe is expected to be the fastest-growing region in the neurotechnology market report during the forecast period. The regions covered in the neurotechnology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Contact Us:

The Business Research Company

https://thebusinessresearchcompany.com/

Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267

Email: info@tbrc.info


Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company